Abstract: Vascular delivery systems configured to deliver an implant to a location within a vasculature can include one or more control wires controllable by a user to detach the implant from the delivery system. Control wires can cause a feature of the delivery system to mechanically engage a hub at a proximal end of an implant. Proximal or distal movement of the control wire can allow the feature to disengage from the hub, thereby allowing release of the implant.

Abstract: Vascular delivery systems configured to deliver an implant to a location within a vasculature can include one or more control wires controllable by a user to detach the implant from the delivery system. Control wires can cause a feature of the delivery system to mechanically engage a hub at a proximal end of an implant. Proximal or distal movement of the control wire can allow the feature to disengage from the hub, thereby allowing release of the implant.

Abstract: Vascular delivery systems configured to deliver an implant to a location within a vasculature can include one or more control wires controllable by a user to detach the implant from the delivery system. Control wires can cause a feature of the delivery system to mechanically engage a hub at a proximal end of an implant. Proximal or distal movement of the control wire can allow the feature to disengage from the hub, thereby allowing release of the implant.

Abstract: Various features are described that are adapted to improve performance of interference-relief type delivery systems. A delivery system provided herein comprises an implant comprising a socket at a proximal end of the implant; an elongate sleeve having (i) a proximal section, (ii) a distal section slidably disposed within the socket, and (iii) a window between the proximal section and the distal section, the window extending through a wall of the sleeve; and a core member having a proximal portion slidably received within the proximal section of the sleeve and a distal portion extending through the window to a space outside the sleeve and within the socket. The distal portion of the core member provides an interference fit with the distal section of the sleeve within the socket until the core member is withdrawn.

Abstract: Embolic implants, delivery systems and methods of manufacture and delivery are disclosed. The subject implants are deployed in two stages. If sized properly as observed in the first stage, they are deployed to the second stage and detached. If not sized properly in/at the first stage, the implants are designed to be withdrawn and replaced with a more appropriately sized implant or another treatment option selected. Some of the implant configurations may be withdrawn even after the second stage deployment as well.

Abstract: Vascular delivery systems configured to deliver an implant to a location within a vasculature can include one or more control wires controllable by a user to detach the implant from the delivery system. Control wires can cause a feature of the delivery system to mechanically engage a hub at a proximal end of an implant. Proximal or distal movement of the control wire can allow the feature to disengage from the hub, thereby allowing release of the implant.

Abstract: Embolic implants, methods of manufacture and delivery are disclosed. The subject implants are especially suitable for use is stent-caged aneurysm treatment.